sb 203580 has been researched along with cyclopentane in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (cyclopentane) | Trials (cyclopentane) | Recent Studies (post-2010) (cyclopentane) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 10,498 | 86 | 5,283 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bornstein, SR; Graessler, J; Kopprasch, S; Saha, S; Schwarz, PE | 1 |
1 other study(ies) available for sb 203580 and cyclopentane
Article | Year |
---|---|
Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.
Topics: Biomarkers; Butadienes; Cell Adhesion; Cyclopentanes; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Janus Kinase 2; Lipoproteins, HDL; Lipoproteins, VLDL; Mitogen-Activated Protein Kinases; Neutrophil Activation; Neutrophils; Nitriles; Phagocytes; Pyridines; Scavenger Receptors, Class B; Thiosemicarbazones; Tyrphostins | 2013 |